JP2013540738A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540738A5
JP2013540738A5 JP2013528677A JP2013528677A JP2013540738A5 JP 2013540738 A5 JP2013540738 A5 JP 2013540738A5 JP 2013528677 A JP2013528677 A JP 2013528677A JP 2013528677 A JP2013528677 A JP 2013528677A JP 2013540738 A5 JP2013540738 A5 JP 2013540738A5
Authority
JP
Japan
Prior art keywords
chloro
indol
dihydro
pyridin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013528677A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013540738A (ja
JP5899218B2 (ja
Filing date
Publication date
Priority claimed from PL39243610A external-priority patent/PL392436A1/pl
Application filed filed Critical
Publication of JP2013540738A publication Critical patent/JP2013540738A/ja
Publication of JP2013540738A5 publication Critical patent/JP2013540738A5/ja
Application granted granted Critical
Publication of JP5899218B2 publication Critical patent/JP5899218B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013528677A 2010-09-17 2011-09-16 Cns疾患の処置のためのアリールスルホンアミド Expired - Fee Related JP5899218B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PLP.392436 2010-09-17
PL39243610A PL392436A1 (pl) 2010-09-17 2010-09-17 Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
PCT/EP2011/066054 WO2012035123A1 (en) 2010-09-17 2011-09-16 Arylosulfonamides for the treatment of cns diseases

Publications (3)

Publication Number Publication Date
JP2013540738A JP2013540738A (ja) 2013-11-07
JP2013540738A5 true JP2013540738A5 (https=) 2014-10-23
JP5899218B2 JP5899218B2 (ja) 2016-04-06

Family

ID=44789428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013528677A Expired - Fee Related JP5899218B2 (ja) 2010-09-17 2011-09-16 Cns疾患の処置のためのアリールスルホンアミド

Country Status (15)

Country Link
US (2) US8822517B2 (https=)
EP (1) EP2616440A1 (https=)
JP (1) JP5899218B2 (https=)
KR (1) KR20130143569A (https=)
CN (2) CN104529999A (https=)
AU (1) AU2011303807B2 (https=)
BR (1) BR112013006313A2 (https=)
CA (1) CA2808246A1 (https=)
EA (1) EA022776B1 (https=)
MX (1) MX2013002956A (https=)
NZ (1) NZ607031A (https=)
PL (1) PL392436A1 (https=)
UA (1) UA109793C2 (https=)
WO (1) WO2012035123A1 (https=)
ZA (2) ZA201302390B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015158313A1 (en) 2014-04-19 2015-10-22 Sunshine Lake Pharma Co., Ltd. Sulfonamide derivatives and pharmaceutical applications thereof
CN106749219A (zh) * 2015-11-20 2017-05-31 江苏恩华药业股份有限公司 一种内酰胺类衍生物及其应用
CN107602446B (zh) * 2016-07-12 2020-04-07 中国科学院上海药物研究所 1,4-双取代-1,2,3,6-四氢吡啶类化合物、其制备方法、药物组合物及其应用
PT4082616T (pt) * 2019-12-24 2025-12-02 Sumitomo Pharma Co Ltd Derivado de amida ácida alifática
CN116157124A (zh) * 2020-05-29 2023-05-23 大邱庆北尖端医疗产业振兴财团 磺胺衍生物和含其作为活性成分的用于预防或治疗精神疾病的药物组合物
KR102447231B1 (ko) * 2020-05-29 2022-09-27 재단법인 대구경북첨단의료산업진흥재단 설폰아미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (https=) * 1974-01-30 1977-09-09 Roussel Uclaf
EP0185429A1 (en) 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
JP2556722B2 (ja) 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
TWI242011B (en) * 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
GB9825413D0 (en) * 1998-11-19 1999-01-13 Lilly Co Eli Pharmaceutical compounds
GB9906624D0 (en) * 1999-03-23 1999-05-19 Smithkline Beecham Plc Novel compounds
MXPA05006463A (es) * 2002-12-27 2005-08-26 Lundbeck & Co As H Derivados de 1,2,4-triaminobenceno, utiles para tratar transtornos del sistema nervioso central.
US7153858B2 (en) 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
CA2637531A1 (en) * 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity

Similar Documents

Publication Publication Date Title
JP2013540738A5 (https=)
AU2017279570B2 (en) Trk-inhibiting compound
JP2005518330A5 (https=)
JP2022506887A5 (https=)
JP2013508412A5 (https=)
JP2006521343A5 (https=)
JP2013519724A5 (https=)
JP2009263394A5 (https=)
JP2014507464A5 (https=)
WO2016089060A2 (en) Heterocyclic derivatives and use thereof
JP2013545798A5 (https=)
JP2004506736A5 (https=)
JP2011519854A5 (https=)
JP2014525420A5 (https=)
JP2007520471A5 (https=)
JP2021536482A5 (https=)
JP2013510178A5 (https=)
JP2004531532A5 (https=)
WO2014196793A1 (en) Heterocyclic derivatives and use thereof
JP2012528839A5 (https=)
JP2014530837A5 (https=)
JP2018526419A5 (https=)
EP1613265A2 (en) Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
CA2405408A1 (en) Pyrazole compounds
JP2016535040A5 (https=)